Selection and Interpretation of Scientific Evidence in Preparation for Policy Decisions: A Case Study Regarding Introduction of Rotavirus Vaccine Into National Immunization Programs in Sweden, Norway, Finland, and Denmark

Gry St-Martin; Ann Lindstr; Synne S; bu; Thea K??lsen Fischer

首页> 外文期刊>Frontiers in Public Health >Selection and Interpretation of Scientific Evidence in Preparation for Policy Decisions: A Case Study Regarding Introduction of Rotavirus Vaccine Into National Immunization Programs in Sweden, Norway, Finland, and Denmark

【24h】

Selection and Interpretation of Scientific Evidence in Preparation for Policy Decisions: A Case Study Regarding Introduction of Rotavirus Vaccine Into National Immunization Programs in Sweden, Norway, Finland, and Denmark

机译：在政策决策准备中的科学证据的选择和解释：在瑞典，挪威，芬兰和丹麦将轮状病毒疫苗引入国家免疫计划的案例研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The World Health Organization recommends inclusion of rotavirus vaccines in national immunization programs (NIPs) worldwide. Nordic countries are usually considered comparable in terms of demographics and health-care services and have comparable rotavirus disease burden. Nevertheless, the countries have reached different decisions regarding rotavirus vaccine: Norway and Finland have already introduced rotavirus vaccines into their NIPs and Sweden is currently changing its recommendation and vaccines will now be introduced on a national scale while Denmark has decided against it. This study focuses on the selection and interpretation of medical and epidemiological evidence used during the decision-making processes in Sweden, Norway, Finland, and Denmark. The so-called “severity criteria” is identified as one of the main reasons for the different policy decisions reached across the Nordic countries.

机译：世界卫生组织建议将轮状病毒疫苗纳入世界范围内的国家免疫计划（NIP）。北欧国家通常被认为在人口统计学和医疗保健服务方面具有可比性，并且轮状病毒疾病负担可比。尽管如此，这些国家对轮状病毒疫苗已经做出了不同的决定：挪威和芬兰已经将轮状病毒疫苗引入其国家实施计划中，瑞典目前正在改变其建议，现在将在全国范围内引入疫苗，而丹麦则对此表示反对。这项研究的重点是在瑞典，挪威，芬兰和丹麦的决策过程中使用的医学和流行病学证据的选择和解释。所谓的“严重性标准”被确定为北欧国家做出不同政策决定的主要原因之一。

著录项

来源
《Frontiers in Public Health》 |2018年第1期|共页
作者
Gry St-Martin; Ann Lindstr; Synne S; bu; Thea K??lsen Fischer;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类个人卫生;
关键词
policy decisionsvaccine introductionrotavirus vaccinesNordic countriespolicy-making processes;

机译：政策决定疫苗引进轮状病毒疫苗北欧国家政策制定过程;

相似文献

外文文献
中文文献

1. Evidence of reduction of rotavirus diarrheal disease after rotavirus vaccine introduction in national immunization programs in the African countries: Report of the 11th African rotavirus symposium held in Lilongwe, Malawi [J] . Vaccine . 2019,第23期

机译：RotaVirus患者患者在非洲国家的国家免疫方案中介绍了RotaVirus腹泻病的证据：第11个非洲轮状病毒研讨会在马拉维举行的报告
2. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland [J] . HemmingM., R?s?nenS., HuhtiL., European journal of pediatrics . 2013,第6期

机译：在芬兰国家免疫计划中引入RotaTeq疫苗后，在医院中发现的儿童轮状病毒（而非诺如病毒）的胃肠炎大幅度减少
3. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012. [J] . Jacqueline E Tate, Amber Haynes, Daniel C Payne, The Pediatric infectious disease journal . 2013,第7期

机译：2000年至2012年，在美国将轮状病毒疫苗引入国家免疫计划之前和之后，国家轮状病毒活动的趋势。
4. Incidence of Brain Tumors and Mobile Phones: a Population-Based Descriptive Study in Denmark, Finland, Norway:and Sweden, 1974-2003 [C] . Isabelle Deltour, Christoffer Johansen, Anssi Auvinen, Meeting of the Bioelectromagnetics Society . 2010

机译：脑肿瘤和移动电话的发病率：丹麦，芬兰，挪威的基于人口的描述性研究：和瑞典，1974-2003
5. Selection and Interpretation of Scientific Evidence in Preparation for Policy Decisions: A Case Study Regarding Introduction of Rotavirus Vaccine Into National Immunization Programs in Sweden Norway Finland and Denmark [O] . Gry St-Martin, Ann Lindstrand, Synne Sandbu, 2018

机译：在决策过程中科学证据的选择和解释：以轮状病毒疫苗引入瑞典挪威芬兰和丹麦的国家免疫计划为例
6. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project11A complete listing of the participants who all contributed equally to the work of the CERTPAP Project includes Peter N. Furness (Leicester, UK); Nicholas Taub (Leicester, United Kingdom); Karel J.M. Assmann (Nijmegen, The Netherlands); Giovanni Banfi (Milan, Italy); John N. Botelis (Athens, Greece); Marta Carrera (Barcelona, Spain); Jean-Pierre Cosyns (Brussels, Belgium); Anthony M. Dorman (Dublin, Ireland); Dominique Droz (Paris, France); Claire M. Hill (Belfast, N. Ireland); Bela Iványi (Kossuth, Hungary); Silke Kapper (Mannheim, Germany); Erik N. Larsson (Uppsala, Sweden); Aryvdas Laurinavicius (Vilius, Lithuania); Niels Marcussen (Aachus, Denmark); Anna Paula Martins (Lisbon, Portugal); Michael J. Mihatsch (Basel, Switzerland); Lydia Nakopoulou (Athens, Greece); Volker Nickeleit (Basel, Switzerland); L-H Nöel (Paris, France); Timo Paavonen (Helsinki, Finland); Agnieszua K. Perkowska (Warsaw, Poland); Heinz Regele (Vienna, Austria); Rafail Rosenthal (Riga, Latvia); Pavel Rossmann (Prague, Czech Republic); Wotgech A. Rowinski (Warsaw, Poland); Daniel Seron (Barcelona, Spain); Stale Sund (Oslo, Norway); Eero I. Taskinen (Helsinki, Finland); Tatjana Tihomirova (Riga, Latvia); and Rudiger Waldherr (Mannheim, Germany). [O] . Furness Peter N., Taub Nicholas 2001

机译：肾移植活检解释上的国际差异：CERTPAP项目的报告11A完整列出了对CERTPAP项目的工作均做出了同等贡献的参与者，其中包括Peter N. Furness（英国莱斯特）； Nicholas Taub（英国莱斯特）； Karel J.M. Assmann（荷兰奈梅亨）; Giovanni Banfi（意大利米兰）； John N. Botelis（希腊雅典）； Marta Carrera（西班牙巴塞罗那）； Jean-Pierre Cosyns（比利时布鲁塞尔）； Anthony M.Dorman（爱尔兰都柏林）； Dominique Droz（法国巴黎）；克莱尔·希尔（Claire M.Hill）（爱尔兰北爱尔兰贝尔法斯特）； BelaIványi（匈牙利科苏特）； Silke Kapper（德国曼海姆）； Erik N. Larsson（瑞典乌普萨拉）； Aryvdas Laurinavicius（立陶宛维留斯）； Niels Marcussen（丹麦Aachus）； Anna Paula Martins（葡萄牙里斯本）； Michael J.Mihatsch（瑞士巴塞尔）； Lydia Nakopoulou（希腊雅典）; Volker Nickeleit（瑞士巴塞尔）； L-HNöel（法国巴黎）； Timo Paavonen（芬兰赫尔辛基）； Agnieszua K.Perkowska（波兰华沙）； Heinz Regele（奥地利维也纳）；拉斐尔·罗森塔尔（Rafail Rosenthal）（拉脱维亚里加）； Pavel Rossmann（捷克共和国布拉格）； Wotgech A.Rowinski（波兰华沙）； Daniel Seron（西班牙巴塞罗那）； Stale Sund（挪威奥斯陆）； Eero I. Taskinen（芬兰赫尔辛基）； Tatjana Tihomirova（拉脱维亚里加）；和Rudiger Waldherr（德国曼海姆）。

Selection and Interpretation of Scientific Evidence in Preparation for Policy Decisions: A Case Study Regarding Introduction of Rotavirus Vaccine Into National Immunization Programs in Sweden, Norway, Finland, and Denmark

摘要

著录项

相似文献

相关主题

期刊订阅